Overview of Liposome-Based Delivery Platforms
Liposome encapsulation is a powerful non-viral delivery method used to transport nucleic acids and proteins into cells with high efficiency and low cytotoxicity. Liposomes are nanoscale, spherical vesicles composed of phospholipid bilayers that mimic the structure of biological membranes. They can encapsulate both hydrophilic and hydrophobic molecules, protect sensitive cargo from enzymatic degradation, and enhance cellular uptake through fusion or endocytosis.
This advanced formulation technology supports the intracellular delivery of a wide range of biologically active molecules—including plasmid DNA, siRNA, miRNA, and functional proteins—for research, therapeutic development, and gene modulation studies. Liposomal encapsulation is widely used in transfection experiments, gene therapy model development, and in vivo biodistribution studies.
Encapsulation of Plasmid DNA for Transfection Applications
Plasmid DNA encapsulated in liposomes offers a highly efficient means of delivering genetic material into mammalian cells. Liposomes protect the DNA from serum nucleases and facilitate cellular internalization through endocytic uptake. Once inside the cell, liposomal delivery systems are engineered to promote endosomal escape and nuclear entry, which is critical for effective transgene expression. Encapsulated DNA is ideal for gene overexpression, CRISPR-Cas9 delivery, and stable cell line development.
siRNA and miRNA Liposome Encapsulation for Gene Silencing
Encapsulation of siRNA or miRNA in liposomes enhances the stability, biodistribution, and intracellular delivery of RNA interference agents. By protecting RNA duplexes from degradation and improving pharmacokinetic properties, liposomes enable efficient gene knockdown in both in vitro and in vivo models. Targeted liposomes can be modified with ligands or surface coatings (e.g., PEGylation) to direct cargo to specific tissues or cell types. These encapsulated formulations are compatible with both transient silencing studies and long-term RNAi pathway investigations.
Protein and Peptide Delivery Using Liposomes
Liposomes also provide an effective method for delivering functional proteins, enzymes, and therapeutic peptides into cells. By encapsulating bioactive proteins, liposomes bypass membrane impermeability and can deliver functional biomolecules directly into the cytoplasm. This is particularly valuable for intracellular enzyme replacement, signaling pathway studies, and protein–protein interaction assays. Proteins encapsulated in liposomes retain their activity and avoid degradation in extracellular environments.
Applications in Research and Preclinical Development
Liposome-encapsulated molecules are widely applied in functional genomics, oncology, immunotherapy, and regenerative medicine. These delivery systems are ideal for developing in vivo gene delivery models, testing candidate therapeutic constructs, and optimizing transfection workflows in difficult-to-transfect cell lines. In preclinical studies, liposomal formulations allow controlled dosing, tissue-specific targeting, and reduced immune activation compared to other delivery platforms.
Technical Highlights and Customization Options
Liposome encapsulation services include formulation design tailored to the physical and chemical characteristics of the cargo—such as size, charge, and hydrophobicity. Particle size is typically tuned to 100–200 nm for optimal uptake. Liposomes can be PEGylated for improved circulation time and surface-modified with targeting ligands such as antibodies, peptides, or small molecules. Each formulation is validated for stability, uniformity, and encapsulation efficiency using standard analytical methods like DLS, zeta potential, and UV absorbance.
Integrated Services for Complex Delivery Needs
Professional liposome encapsulation services support the development of fully customized delivery systems for both academic and biotech applications. These services integrate nucleic acid formulation, protein encapsulation, surface functionalization, and delivery optimization—enabling clients to perform reproducible transfection or gene knockdown experiments across a variety of model systems.
Altogen Labs offers liposome encapsulation of plasmid DNA, siRNA, miRNA, and proteins using validated protocols for in vitro and in vivo delivery. Their services are suitable for therapeutic research, xenograft studies, and stable gene modification applications. More details are available on their service pages.